CA2893951C - Methods of treating or preventing respiratory conditions - Google Patents

Methods of treating or preventing respiratory conditions Download PDF

Info

Publication number
CA2893951C
CA2893951C CA2893951A CA2893951A CA2893951C CA 2893951 C CA2893951 C CA 2893951C CA 2893951 A CA2893951 A CA 2893951A CA 2893951 A CA2893951 A CA 2893951A CA 2893951 C CA2893951 C CA 2893951C
Authority
CA
Canada
Prior art keywords
stro
cells
mpcs
respiratory condition
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2893951A
Other languages
English (en)
French (fr)
Other versions
CA2893951A1 (en
Inventor
Silviu Itescu
Ravi Krishnan
Peter Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast Inc
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of CA2893951A1 publication Critical patent/CA2893951A1/en
Application granted granted Critical
Publication of CA2893951C publication Critical patent/CA2893951C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA2893951A 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions Active CA2893951C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Publications (2)

Publication Number Publication Date
CA2893951A1 CA2893951A1 (en) 2014-06-19
CA2893951C true CA2893951C (en) 2022-05-03

Family

ID=50933587

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2893951A Active CA2893951C (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Country Status (11)

Country Link
US (3) US10028979B2 (cg-RX-API-DMAC7.html)
EP (1) EP2931373B1 (cg-RX-API-DMAC7.html)
JP (5) JP6313327B2 (cg-RX-API-DMAC7.html)
KR (1) KR101748712B1 (cg-RX-API-DMAC7.html)
CN (2) CN115919901A (cg-RX-API-DMAC7.html)
AU (4) AU2013360026B2 (cg-RX-API-DMAC7.html)
CA (1) CA2893951C (cg-RX-API-DMAC7.html)
ES (1) ES2759281T3 (cg-RX-API-DMAC7.html)
IL (1) IL239309A0 (cg-RX-API-DMAC7.html)
SG (2) SG11201504352TA (cg-RX-API-DMAC7.html)
WO (1) WO2014089625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
JP2020533373A (ja) * 2017-09-15 2020-11-19 サイナータ セラピューティクス リミテッド アレルギー性気道疾患(aad)/喘息の処置方法
TW202146033A (zh) * 2020-01-30 2021-12-16 日商Jcr製藥股份有限公司 包含源自牙髓的細胞之醫藥組成物
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US20050118714A1 (en) * 2002-02-19 2005-06-02 Chul-Won Ha Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN102391981B (zh) * 2004-09-24 2014-08-20 麦索布莱斯特公司 多能扩增间充质前体细胞子代(memp)及其应用
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
ES2923016T3 (es) * 2007-08-06 2022-09-22 Mesoblast Inc Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo
JP5539886B2 (ja) * 2007-10-17 2014-07-02 ティクセル Tr1細胞、間葉系幹細胞およびその使用
US8828375B2 (en) * 2008-09-03 2014-09-09 Mesoblast, Inc. Expansion of haemopoietic precursors
AU2011274255B2 (en) * 2010-07-02 2016-05-05 Mesoblast, Inc. Treatment of T-cell mediated immune disorders
KR101947699B1 (ko) * 2011-03-11 2019-02-14 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
CA2837895C (en) * 2011-06-03 2021-07-27 Mesoblast, Inc. Methods of treating or preventing neurological diseases
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Also Published As

Publication number Publication date
US20150306146A1 (en) 2015-10-29
US20200289578A1 (en) 2020-09-17
US10688134B2 (en) 2020-06-23
AU2018226514B2 (en) 2020-01-02
EP2931373B1 (en) 2019-08-21
JP2018118987A (ja) 2018-08-02
KR20150090237A (ko) 2015-08-05
AU2013360026A1 (en) 2015-07-02
JP2016502980A (ja) 2016-02-01
AU2018226514A1 (en) 2018-09-27
JP2024041904A (ja) 2024-03-27
JP6313327B2 (ja) 2018-04-18
KR101748712B1 (ko) 2017-06-19
US20190046575A1 (en) 2019-02-14
AU2022209219A1 (en) 2022-08-18
JP6665218B2 (ja) 2020-03-13
JP7420844B2 (ja) 2024-01-23
AU2020202022A1 (en) 2020-04-09
HK1210077A1 (en) 2016-04-15
WO2014089625A1 (en) 2014-06-19
AU2013360026B2 (en) 2018-06-21
SG10201807682PA (en) 2018-10-30
AU2022209219B2 (en) 2025-08-14
EP2931373A1 (en) 2015-10-21
EP2931373A4 (en) 2016-05-04
SG11201504352TA (en) 2015-07-30
IL239309A0 (en) 2015-07-30
CA2893951A1 (en) 2014-06-19
CN105377274A (zh) 2016-03-02
ES2759281T3 (es) 2020-05-08
US10028979B2 (en) 2018-07-24
JP2020097618A (ja) 2020-06-25
JP2022065132A (ja) 2022-04-26
CN115919901A (zh) 2023-04-07

Similar Documents

Publication Publication Date Title
AU2018226514B2 (en) Methods of treating or preventing respiratory conditions
US20190201448A1 (en) Methods of treating or preventing neurological diseases
AU2019202960A1 (en) Treatment of diseases of endothelial dysfunction and inflammation
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation
HK40014520A (en) Treatment of diseases of endothelial dysfunction and inflammation

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20181122